Aspira Pathlab & Diagnostics Q2 FY27 Results: Net Loss of ₹1.2 Cr
Aspira Pathlab & Diagnostics Ltd reported revenue from operations of ₹6.3 Cr (-22.2% YoY) and a net loss of ₹1.2 Cr for Q2 FY27.
- Key figure
- Net loss ₹1.2 Cr
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Aspira Pathlab & Diagnostics Ltd reported revenue from operations of ₹6.3 Cr (-22.2% YoY) and a net loss of ₹1.2 Cr for Q2 FY27.
Aspira Pathlab & Diagnostics Ltd reported revenue from operations of ₹6.2 Cr (+19.2% YoY) and net profit of ₹0 Cr for Q1 FY27.
Aspira Pathlab & Diagnostics Ltd reported revenue from operations of ₹6.5 Cr (+12.1% YoY) and a net loss of ₹0.6 Cr for Q4 FY26.
Aspira Pathlab approved its audited standalone financial results for the year ended March 31, 2026. The board also appointed new management and an internal auditor.